Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Arbitration Update

31 Aug 2010 07:00

RNS Number : 8039R
Biofutures International plc
31 August 2010
 



Biofutures International plc

("Biofutures" or the "Company")

 

Arbitration Update

 

31 August 2010

 

Biofutures announces that the arbitration hearing in relation to the dispute between the Company's wholly-owned subsidiary, Zurex Corporation Sdn Bhd ("Zurex"), and JJ-Lurgi Engineering Sdn Bhd ("Lurgi") has concluded after all witnesses were heard.

 

Following the hearing, the Arbitrator, Tan Sri Abdul Aziz Bin Mohamad, has ordered that Zurex must file a written submission on or before 22 November 2010, Lurgi must file its written submission on or before 31 January 2001 and Zurex must then file a submission in reply on or before 16 March 2011. Clarification before the Arbitrator will then take place on 3 May 2011, at which point the Arbitrator will either seek further elaboration on any issues raised or deliver his award.

 

The Company will provide further updates as the arbitration procedure progresses.

 

For further information please contact:

 

Enquiries:

 

 

 

Joe Wong

Chief Executive Officer

 

Biofutures International plc

Tel:  +6012 31 0626

 

Derek Crowhurst /

Wye-Li Long

 

Religare Capital Markets

(Nomad)

 

Tel: 020 7444 0800

 

Daniel Briggs

 

Religare Capital Markets

(Broker)

Tel: 020 7444 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGZRVNMGGZM
Date   Source Headline
9th Apr 200911:50 amRNSHolding(s) in Company
20th Feb 20099:07 amRNSRe Contract
13th Feb 20091:46 pmRNSHolding(s) in Company
11th Feb 20095:25 pmRNSHolding(s) in Company
10th Feb 20098:43 amRNSHolding(s) in Company
6th Feb 20095:15 pmRNSHolding(s) in Company
14th Jan 20098:39 amRNSHolding(s) in Company
5th Jan 200912:09 pmRNSDirectors' Share Purchases
17th Nov 200812:08 pmRNSStatement re Commencement of Refinery Project
4th Nov 20082:55 pmRNSTrading Update
29th Sep 200810:49 amRNSInterim Results
29th Aug 20085:05 pmRNSGrant of Options
30th Jul 200811:32 amRNSAGM Statement
22nd Jul 200810:00 amRNSHolding in Company
30th Jun 200812:00 pmRNSHolding in Company
27th Jun 200812:24 pmRNSPosting of Annual Report and
24th Jun 200811:39 amRNSFinal Results
18th Jun 20087:00 amRNSHolding in Company
6th Jun 200812:30 pmRNSEGM Statement
20th May 20084:35 pmRNSNotice of EGM
16th May 20084:35 pmRNSLand In Malaysia
16th May 20081:48 pmRNSHolding(s) in Company
10th Apr 200810:45 amRNSHolding(s) in Company
4th Mar 20083:13 pmRNSHolding in Company
4th Mar 20087:02 amRNSHolding in Company
6th Feb 20088:07 amRNSBoard Appointment
19th Dec 20079:55 amRNSBoard Change
1st Nov 20072:55 pmRNSChange of NOMAD
27th Sep 20077:04 amRNSInterim Results
31st Aug 20074:58 pmRNSChange of NOMAD
31st Aug 20078:38 amRNSTotal Voting Rights
28th Aug 20078:48 amRNSChange of registered address
17th Aug 20075:00 pmRNSAIM Rule 26
1st Aug 20078:57 amRNSUpdate
30th Jul 20073:55 pmRNSResult of AGM
30th Jul 200710:27 amRNSTrading Statement
2nd Jul 20073:39 pmRNSNotice of AGM
28th Jun 20074:27 pmRNSAnnual Report and Accounts
21st Jun 20077:01 amRNSFinal Results
3rd May 200710:47 amRNSPhillip Carter
2nd May 20071:37 pmRNSPhillip Carter
20th Mar 200711:27 amRNSHolding(s) in Company
9th Mar 20072:38 pmRNSLaunch of Biofutures Website
9th Mar 200711:40 amRNSHolding(s) in Company
1st Mar 20077:07 amRNSMembership of RSPO
23rd Feb 20077:01 amRNSBoard Changes
9th Feb 20072:41 pmRNSNon Exec Director Appointment
30th Jan 20071:01 pmRNSContract
23rd Jan 20073:30 pmRNSDirector's Shareholding
6th Dec 20062:51 pmRNSVoting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.